Genome editing or genome engineering is the technique that enables scientists to make modifications in an individual’s DNA. This also includes alterations in different organisms, such as bacteria, plants, and the animals. DNA editing result in changes in the physical attributes, such as color of eyes, disease risk, and more. Today, scientists are making use of various technologies to execute this process. Presently, the CRISPR technology is trending across the globe in the genome engineering field. Researchers more often make use of this improved and highly efficient technology, CRISPR to control the genome to learn the gene functionality. Nonetheless, the latest improvements in the field of gene editing technology have indicated it to be the most promising and therapeutic means also.
Genome Editing/Genome Engineering Market was valued at over US$ 3.0 Bn. in 2017 and is anticipated to grow at a CAGR of 14.1% from 2019 to 2030.
The growth of this market can be attributed to the major factor that is utilization of the technique for therapeutic genetic editing in infected tissues and cells, thereby reducing the mutations.
Major Key Players of the Genome Editing/Genome Engineering Market are:
Thermo Fisher Scientific, Lonza, Merck, Horizon Discovery Group, Integrated DNA Technologies, New England Biolabs (US), GenScript (US), Sangamo BioSciences (US), OriGene Technologies (US), Transposagen Biopharmaceuticals (US), Editas Medicine (US), and CRISPR Therapeutics (Switzerland)., among others.
Download PDF to Know the Impact of COVID-19 on “Genome Editing/Genome Engineering Market” at: https://www.marketindustryreports.com/pdf/5
Strong product pipeline are anticipated to impact the industrial growth over the forecast period of 2019–2030. The novel products are designed to help in development of DNA targeting, with improved flexibility, specificity of nuclease, and the ease of Adeno-Associate Virus (AAV) packaging for delivery. Moreover, utilization of the technique through a number of methods such as disruption of viral DNA, correction in the toxic mutations, or the addition of therapeutic transgenes is projected to boost the adoption.
The Genome Editing/Genome Engineering Market is segmented on the basis of Technology, Applications, End Users and region.
Major Technology of Genome Editing/Genome Engineering Market covered are:
- CRISPR
- TALEN
- ZFN
Major Applications of Genome Editing/Genome Engineering Market covered are:
- Cell Line Engineering
- Genetic Engineering
Major End Users of Genome Editing/Genome Engineering Market covered are:
- Research Centers
- Pharmaceutical & Biotechnology Companies
- CROs
Application of the technology for cell line genetic editing or engineering in the form of gene therapy and stem cell therapy accounted for the considerable share and is estimated to register lucrative growth. Furthermore, use of the genome editing technology for the development of novel molecules which can be targeted for treating various diseases such as infectious diseases and hematological malignancies is likely to drive the adoption of the technology in the coming years.
Toxicity owing to off-target effects of the nucleases is a major safety concern for the market restraining the market growth. In addition, the IP disputes relating to CRISPR technology between the industry players is estimated to restrain growth in near future.
Research objectives:-
– To study and analyze the global Genome Editing/Genome Engineering consumption (value & volume) by key regions/countries, product type and application, history data.
– To understand the structure of the Genome Editing/Genome Engineering Market by identifying its various sub-segments.
– Focuses on the key global Genome Editing/Genome Engineering manufacturers, to define, describe and analyze the sales volume, value, market share, market competitive landscape, SWOT analysis, and development plans in the next few years.
– To analyze the Genome Editing/Genome Engineering with respect to individual growth trends, future prospects, and their contribution to the total market.
– To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Table of Contents
- INTRODUCTION
- Market Definition
- Market Ecosystem
- Currency Used for the Study
- Report Beneficiary List
- RESEARCH METHODOLOGY
- Research Framework
- Data Collection Technique
- Data Sources
- Market Estimation Methodology
- Data Validation and Triangulation
- ABSTRACT OF THE STUDY
- MARKET DYNAMICS ASSESMENT
- Overview
- Drivers
- Barriers/Challenges
- Opportunities
- UNIQUE SELLING PROPOSITIONS (USPs)
- Technological Advancement
- Initiatives Assessment: Government & Private Bodies
- GLOBAL GENOME EDITING/GENOME ENGINEERING MARKET – ANALYSIS & FORECAST, BY TECHNOLOGY
- Introduction & Definition
- TALEN (Transcription activator-like effector nucleases)
- CRISPR
- ZFN
- Other Technologies
- GLOBAL GENOME EDITING/GENOME ENGINEERING MARKET – ANALYSIS & FORECAST, BY APPLICATION
- Introduction
- Genetic Engineering
- Cell Line Engineering
- Other Applications
- GLOBAL GENOME EDITING/GENOME ENGINEERING MARKET – ANALYSIS & FORECAST, BY END USER
- Introduction
- Academic Institutes & Research Centers
- Contract Research Organization
- Pharmaceutical & Biotechnology Companies
- Other End User
- GLOBAL GENOME EDITING/GENOME ENGINEERING MARKET – ANALYSIS & FORECAST, BY REGION
- North America Genome Editing/Genome Engineering Market
- Europe Genome Editing/Genome Engineering Market
- Asia Pacific Genome Editing/Genome Engineering Market
- Rest of the World (ROW) Genome Editing/Genome Engineering Market
- COMPETETIVE LANDSCAPE
- Market Share Analysis (2018)
- Key Strategies Assessment
- New Product Launches
- Merger & Acquisitions
- Agreements, Collaborations, & Partnerships
- Expansions
- Other Strategies
- COMPANY PROFILES (Business Overview, Products/Services Offered, Financial Performance, R&D Intensity, Marketing & Sales Intensity, Recent Developments, Analyst Corner)*
- Merck Group
- Horizon Discovery Group
- Genescript
- Thermo Fisher Scientific
- Lonza
- Origene Technologies
- New England Biolabs
- Sangamo Bioscience
- Editas Medicine, Inc.
- CRISPR Therapeutics AG (*Financial details might not be captured in case of privately-held companies or for companies that do not report this information in public domain)
- APPENDIX
Buy Exclusive Report @ https://www.marketindustryreports.com/checkout/5
About Us
Market Industry Reports is a global leader in market measurement and advisory services. It is 100% subsidiary of Maniks Systems Pvt Ltd. The firm has always been at the forefront of innovation to address the worldwide industry trends and opportunities.
We offer our clients a unique depth of market intelligence in an actionable format to move their business forward. Our analysis incorporates the consumer study in more than 100 countries that provide a tactical approach to drive the sustained growth for the business. We continue to pioneer state-of the art approach in research & analysis that makes complex world simpler to stay ahead of the curve. By nurturing the perception of genius and optimized market intelligence we bring proficient contingency to our clients in the evolving world of technologies, megatrends and industry convergence. We empower and inspire Vanguards to fuel and shape their business to build and grow world-class consumer products.
Contact Us-
Email: sales@marketindustryreports.com
Phone: + 91 8956767535
Website: https://www.marketindustryreports.com
